Mylan announces new VP global business development
PITTSBURGH Generic drug maker Mylan announced Tuesday that it made an appointment to its executive leadership team.
Mylan appointed former Merrill Lynch investment banker Andrew Cuneo as VP global business development. The company said Cuneo is responsible for coordinating its global business development and strategic efforts.
“Drew brings a wealth of experience in the pharmaceutical, biotechnology and healthcare sectors,” Mylan vice chairman and CEO Robert Coury said in a statement. “His familiarity with our industry – and in particular with Mylan, given his and Merrill Lynch’s active role with the company during the past five years – makes him ideally suited to support the company’s continued growth.”
Most recently, Cuneo served as Merrill Lynch’s director in its global healthcare investment banking group. He earned his bachelor’s degree in economics and psychology from Vanderbilt University.
Optimer receives production patent for CDI treatment
SAN DIEGO The U.S. Patent and Trademark Office has issued a production patent to Optimer Pharmaceuticals covering steps used in the manufacture of fidaxomicin, Optimer announced Monday.
The drug is in phase 3 testing as a treatment for Clostridium difficile infection, also known as CDI.
“The issuance of this production patent is another important milestone in strengthening the patent estate of our lead product candidate, fidaxomicin,” Optimer president and CEO Michael Chang stated. “We believe this patent and the issued polymorphic Form A patent, along with additional pending patent applications, will enhance our intellectual property protection for fidaxomicin.”
CDI causes inflammation of the colon, which often results in diarrhea but can also cause death in extreme cases.
Walgreens sees boom in e-prescriptions
DEERFIELD, Ill. The shift to paperless prescribing took a big leap forward at Walgreens in March, with a tripling in the number of prescriptions filled electronically from year-earlier levels. And new government incentives to doctors will quickly push that level higher still, Walgreens predicted.
Walgreens pharmacies filled a record 3.1 million prescriptions electronically last month, marking a 211% increase compared with March of last year, the company reported Monday. Even more striking: the total number of scripts sent via doctors’ e-prescribing systems and filled by Walgreens last month accounted for 15% of all the drug store chain’s eligible prescriptions.
Walgreens estimated it will fill more than 40 million electronic prescriptions this year, compared with 15 million filled in 2008. The company said it expects growth to continue, as the federal government in January began providing financial incentives for doctors to transmit prescriptions electronically for Medicare patients as part of its campaign to nudge the nation’s healthcare system toward health information technology and electronic record-keeping.
Under that incentive program, doctors will earn a 2% bonus on their covered Medicare reimbursements for every Medicare script they transmit electronically instead of via a handwritten prescription handed to the patient.
Don Huonker, Walgreens’ senior VP of heath care innovation, hailed the continued growth in e-prescriptions and said it contributes to lower health care costs and better patient health.
“Prescriptions transmitted electronically increase the likelihood that patients will get their prescriptions filled, benefit from their drug therapy and avoid more expensive medical procedures,” Huonker said. “E-prescribing improves patient safety and quality of care by reducing medication errors and adverse drug events while also reducing time spent on the phone with physician offices to clarify hand-written prescriptions. The fewer times our pharmacists need to call a physician’s office and verify a prescription, the more time they have to focus on drug interactions, the right dosing and patient consultation.”
Walgreens launched an early, rudimentary e-prescribing network in 1992, making it “the first pharmacy to launch an electronic prescribing system” as well as “the industry leader in filling electronic prescriptions,” the company asserts in a statement. Nationally, some 4% of all eligible prescriptions were transmitted electronically last year, according to SureScripts, the country’s largest secure electronic prescribing network.